Evidence map›Paper›PMID 38259614›Full record

ArticleFrontiers in genetics2023

Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide.

Tonia Carter, Robert K Valenzuela, Srinivasulu Yerukala Sathipati, Rafael Medina-Flores

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Genomic Impacts of Biological Exposures.Journal of developmental biology · 2026
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tonia CarterCenter for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, United States.
Robert K ValenzuelaCenter for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, United States.
Srinivasulu Yerukala SathipatiCenter for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, United States.
Rafael Medina-FloresDepartment of Pathology (Neuropathology), Marshfield Clinic, Marshfield, WI, United States.
Marshfield Clinic · USMarshfield Clinic · US

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
NCATS NIH HHS UL1 TR000427NCATS NIH HHS UL1 TR002373
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemotherapy resistanceglioblastomaoncogenesomatic varianttemozolomide

Identifiers

PMID38259614
PMCPMC10802164
OpenAlexW4389918459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.